David Vickers1, Raúl C Mainar-Jaime, Punam Pahwa. 1. Department of Community Health and Epidemiology, College of Medicine, University of Saskatchewan, Saskatoon, SK. david.vickers@usask.ca
Abstract
BACKGROUND: Few Canadian studies have studied re-emergent pertussis in rural areas. This study described the epidemiology of pertussis in the rural areas of the Saskatoon Regional Health Authority in Saskatchewan, and comparisons were made to the City of Saskatoon. METHODS: Analyses were based on passive surveillance data collected between 1995 and 2003. Estimates of the cumulative incidence (per 10,000 population) measured the occurrence of pertussis. Kaplan-Meier curves were plotted to compare a case's time until disease from their last vaccination by different vaccine types (whole-cell (WCV), or acellular (ACV)) and vaccine histories (complete or partial). Epidemic curves identified peaks in the incidence and checked for seasonal variation in case reporting. RESULTS: Over the 9-year period, 1,135 cases were reported. Rural areas had higher incidence rates and lower proportions of cases vaccinated than urban areas. Overall, the highest age-specific incidence was observed in people aged 10-19 years. Cases aged 0-9 years vaccinated with the ACV, from both rural and urban areas, presented a shorter time to disease (14 months (95% CI: 13-16) and 17 months (95% CI: 11-21), respectively) when compared to cases vaccinated with the WCV (47 months (95% CI: 40-51) and 36 months (95% CI: 31-41), respectively), or with a combination of the two vaccines (40 months (95% CI: 27-47) and 44 months (95% CI: 36-51), respectively, p<0.01). Epidemic curves revealed that reported cases are occurring earlier in successive years (1997, 1999, and 2003) in rural areas. CONCLUSION: Epidemiologic differences among cases from rural areas exist when compared to urban areas. This study further emphasizes the need to better understand age-, vaccine-, and seasonally-related aspects of pertussis epidemiology in rural areas.
BACKGROUND: Few Canadian studies have studied re-emergent pertussis in rural areas. This study described the epidemiology of pertussis in the rural areas of the Saskatoon Regional Health Authority in Saskatchewan, and comparisons were made to the City of Saskatoon. METHODS: Analyses were based on passive surveillance data collected between 1995 and 2003. Estimates of the cumulative incidence (per 10,000 population) measured the occurrence of pertussis. Kaplan-Meier curves were plotted to compare a case's time until disease from their last vaccination by different vaccine types (whole-cell (WCV), or acellular (ACV)) and vaccine histories (complete or partial). Epidemic curves identified peaks in the incidence and checked for seasonal variation in case reporting. RESULTS: Over the 9-year period, 1,135 cases were reported. Rural areas had higher incidence rates and lower proportions of cases vaccinated than urban areas. Overall, the highest age-specific incidence was observed in people aged 10-19 years. Cases aged 0-9 years vaccinated with the ACV, from both rural and urban areas, presented a shorter time to disease (14 months (95% CI: 13-16) and 17 months (95% CI: 11-21), respectively) when compared to cases vaccinated with the WCV (47 months (95% CI: 40-51) and 36 months (95% CI: 31-41), respectively), or with a combination of the two vaccines (40 months (95% CI: 27-47) and 44 months (95% CI: 36-51), respectively, p<0.01). Epidemic curves revealed that reported cases are occurring earlier in successive years (1997, 1999, and 2003) in rural areas. CONCLUSION: Epidemiologic differences among cases from rural areas exist when compared to urban areas. This study further emphasizes the need to better understand age-, vaccine-, and seasonally-related aspects of pertussis epidemiology in rural areas.
Authors: Mark S Peppler; Sharee Kuny; Anna Nevesinjac; Christina Rogers; Yvon R de Moissac; Kathleen Knowles; Manon Lorange; Gaston De Serres; James Talbot Journal: J Clin Microbiol Date: 2003-07 Impact factor: 5.948
Authors: M E Pichichero; M A Deloria; M B Rennels; E L Anderson; K M Edwards; M D Decker; J A Englund; M C Steinhoff; A Deforest; B D Meade Journal: Pediatrics Date: 1997-11 Impact factor: 7.124
Authors: S A Halperin; D Scheifele; L Barreto; C Pim; R Guasparini; L Medd; W Meekison; B J Eastwood Journal: Pediatr Infect Dis J Date: 1999-09 Impact factor: 2.129
Authors: Danuta M Skowronski; Gaston De Serres; Diane MacDonald; Wrency Wu; Carol Shaw; Jane Macnabb; Sylvie Champagne; David M Patrick; Scott A Halperin Journal: J Infect Dis Date: 2002-04-22 Impact factor: 5.226
Authors: F Simondon; M P Preziosi; A Yam; C T Kane; L Chabirand; I Iteman; G Sanden; S Mboup; A Hoffenbach; K Knudsen; N Guiso; S Wassilak; M Cadoz Journal: Vaccine Date: 1997-10 Impact factor: 3.641
Authors: Inma Crespo; Sonia Broner; Núria Soldevila; Ana Martínez; Pere Godoy; Maria-Rosa Sala-Farré; Maria Company; Cristina Rius; Angela Domínguez; The Pertussis Working Group Of Catalonia Journal: Hum Vaccin Immunother Date: 2014-11-01 Impact factor: 3.452
Authors: Sumana Fathima; Christina Ferrato; Bonita E Lee; Kimberley Simmonds; Lin Yan; Shamir N Mukhi; Vincent Li; Linda Chui; Steven J Drews Journal: BMC Infect Dis Date: 2014-01-30 Impact factor: 3.090